Código QR (código de barras bidimensional)

Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study

Abstract Background Continued use of tenofovir disoproxil fumarate (TDF), an antiretroviral drug, causes renal function decline and tubular damage in individuals with HIV. While tenofovir alafenamide fumarate (TAF) may have less damaging effects, it causes weight gain and abnormal lipid metabolism....

תיאור מלא

שמור ב:
Principais autores: Kensuke Abe, Junji Imamura, Akiko Sasaki, Tomoko Suzuki, Satomi Kamio, Taku Obara, Toshihiro Ito
פורמט: Artigo
שפה:Inglês
יצא לאור: BMC 2024-02-01
סדרה:Journal of Pharmaceutical Health Care and Sciences
נושאים:
Renal function
Lipid metabolism
HIV
Tenofovir disoproxil fumarate
Tenofovir alafenamide fumarate
גישה מקוונת:https://doi.org/10.1186/s40780-024-00336-y
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים